NIH delivers gene therapy to the inside of mitochondria; Bio-Path completes toxicity study of its infusion-based cancer candidate;

> NIH researchers have deployed an adeno-associated virus that enters mitochondria to deliver DNA to improve the vision of mice. More

> Bio-Path Holdings successfully completed a Phase Ib toxicity study of its lead compound, Liposomal Grb-2, for patients with advanced acute myeloid leukemia. It uses the company's liposomal delivery technology that enables intravenous infusions. More